European Journal of Cancer
Volume 46, Issue 2 , Pages 348-354, January 2010

EORTC study 26041-22041: Phase I/II study on concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) with PTK787/ZK222584 (PTK/ZK) in newly diagnosed glioblastoma

  • Alba A. Brandes

      Affiliations

    • Bellaria and Maggiore Hospitals, Bologna, Department of Medical Oncology, Italy
    • Corresponding Author InformationCorresponding author: Address: Medical Oncology, Bellaria and Maggiore Hospitals, Azienda ASL Bologna, Via Altura 3, Bologna, Italy. Tel.: +39 0516225101; fax: +39 0516225057.
    • ,
  • Roger Stupp

      Affiliations

    • Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland
    • ,
  • Peter Hau

      Affiliations

    • Department of Neurology, University of Regensburg, Germany
    • ,
  • Denis Lacombe

      Affiliations

    • EORTC – European Organization for Research and Treatment of Cancer Data Center, Bruxelles, Belgium
    • ,
  • Thierry Gorlia

      Affiliations

    • EORTC – European Organization for Research and Treatment of Cancer Data Center, Bruxelles, Belgium
    • ,
  • Alicia Tosoni

      Affiliations

    • Bellaria and Maggiore Hospitals, Bologna, Department of Medical Oncology, Italy
    • ,
  • Renè O. Mirimanoff

      Affiliations

    • Department of Radiation Oncology, Lausanne, Switzerland
    • ,
  • Johan M. Kros

      Affiliations

    • Department of Pathology, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands
    • ,
  • Martin J. van den Bent

      Affiliations

    • Department of Neuro-Oncology, Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

Received 3 September 2009; received in revised form 22 October 2009; accepted 29 October 2009. published online 30 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(09)00816-8

doi:10.1016/j.ejca.2009.10.029

European Journal of Cancer
Volume 46, Issue 2 , Pages 348-354, January 2010

Article Tools

* Image Usage & Resolution